About
Dr. Heiner Dreismann joined SV Life Sciences as a Venture Partner in 2011. He is an active member of the in vitro diagnostics (IVD) industry community and serves on the boards of several innovative public and private diagnostic companies. Prior Experience: Dr. Dreismann is a seasoned executive with more than 26 years of experience in the health care industry, and is regarded as a pioneer in the early adoption of the polymerase chain reaction (PCR) technique, one of the most ubiquitous technologies in molecular biology and genetics research today. He had a successful career at the Roche Group from 1985 to 2006 where he held several senior positions, including President and CEO, Roche Molecular Systems, Head of Global Business Development, Roche Diagnostics and Member of Roche's Global Diagnostic Executive Committee
Position in the VCSift Database
- • 4 investors at DNA Script are tracked.
- • 243 investors hold the Board Member role in VCSift. Heiner Dreismann is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Heiner
Search Investors